Search Within

Solid Tumor Oncology Division

Formats
  1. Journal Article (10931)
  2. Meeting Abstract (9499)
  3. Review (556)
  4. Book Section (417)
  5. Editorial (336)
  6. Guidelines (158)
  7. Correspondence (118)
  8. Conference Paper (107)
  9. Research Letter (61)
  10. Miscellaneous (54)
  11. Book Whole (27)
Groups
  1. Department of Medicine (22241)
  2. GSK Faculty (5929)
  3. Genitourinary Oncology Service (5650)
  4. Survivorship Research (5226)
  5. Gastrointestinal Oncology Service (4692)
  6. Breast Medicine Service (4155)

More Groups

People
  1. Robert Motzer (1247)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (872)
  6. Leonard Saltz (792)

More People

Years
  1. 2025 (641)
  2. 2024 (1388)
  3. 2023 (1381)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1536)

More Years

Publications
  1. Journal of Clinical Oncology (5288)
  2. Annals of Oncology (1297)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (776)
  5. Journal of Thoracic Oncology (532)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5580)
  2. Elsevier Inc. (2662)
  3. American Association for Cancer Research (2327)
  4. Oxford University Press (1819)
  5. Nature Publishing Group (1043)
  6. Springer (981)

More Publishers

Results (22264)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
    Journal Article

    McIntyre, C. A.; Grimont, A.; Park, J.; Meng, Y.; Sisso, W. J.; Seier, K.; Jang, G. H.; Walch, H.; Aveson, V. G.; Falvo, D. J.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Optimizing rectal cancer treatment: A path towards personalization
    Editorial

    Romesser, P. B.; Cercek, A.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
    Journal Article

    Hickman, R. A.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gewirtz, A. N.; more...
    Acta Neuropathologica Communications (2024)

    Fulltext@MSK | Save
  • Leveraging data aggregators to annotate deidentified genomic data derived from commercial laboratory specimens to study COVID-19 severity
    Meeting Abstract

    Dandiker, S.; Latham, A.; Tanpaiboon, P.; Ratajski, A. M.; Bare, L.; Chanock, S.; Fesko, Y. A.; Joseph, V.; Offit, K.
    Value in Health (2024)

    Fulltext@MSK | Save
  • Real-world experience of patients newly initiated on pexidartinib for tenosynovial giant cell tumor
    Meeting Abstract

    Dai, D.; Tecson, K.; Pan; Ye, X.; Tap, W. D.
    Value in Health (2024)

    Fulltext@MSK | Save
  • Assessment of supporting evidence and postmarketing requirements for therapeutic indications with Real-Time Oncology Drug Review, 2018-2023
    Meeting Abstract

    Mooghali, M.; Mohammad, A.; Wallach, J. D.; Mitchell, A. P.; Ross, J. S.; Ramachandran, R.
    Value in Health (2024)

    Fulltext@MSK | Save
  • Pre-surgical visceral adipose tissue may be a novel pre-surgical risk factor for acute kidney injury among clear cell renal cell cancer patients undergoing radical nephrectomy
    Meeting Abstract

    Sanchez, A.; Olson, L.; Knezevic, A.; Akin, O.; Scott, J. S.; Mourtzakis, M.; Hakimi, A. A.; Russo, P.; Jaimies, E.; Bradshaw, P.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Real-world treatment patterns and clinical outcomes of metastatic renal cell carcinoma patients post immune-oncology (IO) and vascular endothelial growth factor (VEGF) receptor targeted therapies
    Meeting Abstract

    Shah, N.; Sura, S.; Shinde, R.; Wentworth, C.; Conkling, P.; Bupathi, M.; Perini, R.; Vickery, D.; Motzer, R.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Health-related quality of life from a phase 4 global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor (TGCT) previously treated with pexidartinib
    Meeting Abstract

    Desai, J.; Wagner, A. J.; Garcia, I. C.; Cesari, M.; Gordon, M.; Lin, C. C.; Papai, Z.; Ryan, C. W.; Tap, W. D.; Trent, J. C.; more...
    Value in Health (2024)

    Fulltext@MSK | Save